Rehmannia Glutinosa Pharmacopuncture Solution Regulates Functional Activation, FcεRI Expression, and Signaling Events in Mast Cells

摘要

Objectives: Rehmannia glutinosa pharmacopuncture solution (RGPS) was investigated to determine both its anti-allergic inflammatory effects on mast cells and its detailed mechanism of actions. Methods: We investigated whether RGPS suppress cytokines, enzymes, expression and -mediated signaling in RBL-2H3 cells stimulated with anti-DNP IgE/DNP-HSA. The suppressive effects of RGPS on the levels of cytokines such as IL- , IL-6 and GM-CSF were measured using emzyme-linked immunospecific assay (ELISA). The mRNA expression levels of cytokines, enzymes (HDC2, COX-1, COX-2 and 5LO) and subunits were measured using reverse transcription polymerase chain reaction (RT-PCR) method. The activation of -mediated signaling was examined using Western blot analyses. Results: RGPS suppressed production of proinflammatory cytokines (IL- , IL-6, and GM-CSF) in stimulated RBL-2H3 cells significantly (p , and were lowered by treatment with RGPS. Finally, RGPS prevented phosphrylation of Lyn, Syk, LAT, Gab2, PLC , PI3K, Akt, cPLA2 and . Conclusions: RGPS effectively suppresses mast cell activations such as degranulation and inflammatory response via down-regulation of the -mediated signaling pathways in IgE/Ag-stimulated mast cells.